Celldex Therapeutics
CLDX
CLDX
115 hedge funds and large institutions have $710M invested in Celldex Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5.84% less ownership
Funds ownership: 93.04% → 87.2% (-5.8%)
12% less funds holding
Funds holding: 130 → 115 (-15)
45% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 33
Holders
115
Holding in Top 10
4
Calls
$22.4M
Puts
$16.3M
Top Buyers
| 1 | +$37M | |
| 2 | +$13.9M | |
| 3 | +$10M | |
| 4 |
VA
VR Adviser
New York
|
+$9.08M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.96M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$17.5M | |
| 3 | -$15.8M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$12.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.4M |